A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis

Clinical trial NCT01640054 · TERMINATED

Trial details

NCT number: NCT01640054
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2012-07-01
Primary completion: 2013-07-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.